Outpatient Endocrine Protocol and Testing Coincides with Reduced Length of Postpituitary Surgery Admission

Abstract

Objective

The study objective was to compare the length of stay (LOS) and the proportion of one-night admissions before and after the implementation of an endocrine monitoring protocol following endoscopic transsphenoidal surgery (ETSS) for pituitary adenoma.

Methods

Patients who underwent transsphenoidal pituitary adenoma resection between July 1, 2018, and September 9, 2022, were identified, and divided into two cohorts before and after the implementation of the monitoring protocol. The overall LOS and number of nights of admission were recorded. Readmission within 30 days after surgery was also recorded. The number of outpatient laboratory tests performed and the time to the first test were also noted.

Results

Thirty patients were identified in the preprotocol group and 60 in the postprotocol group. The average admission length in the preprotocol group was significantly longer than the average admission length in the postprotocol group (2.4 vs. 1.7 days, p = 0.004). The percentage of one-night admissions increased from 13 to 57% (p < 0.001). There were no significant differences in readmission rates between the two groups (p = 0.681). The number of laboratory encounters increased from a mean of 1.38 to 2.40 (p = 0.030), while the time to the first test decreased from a mean of 3.43 to 2.36 days (p = 0.049).

Conclusion

Patients admitted after ETSS for pituitary adenoma had shorter hospital stay and greater proportion of one-night admission with the implementation of an endocrine monitoring protocol. The all-cause readmission rate was not statistically different between the two groups. Through aggressive outpatient laboratory monitoring, one-night admission for ETSS may be feasible.

Keywords

pituitary adenoma - endoscopic surgery - postoperative stay - duration - readmission rate

Previous Presentation

This manuscript is associated with a podium presentation at 33rd Annual North American Skull Base Society Meeting, February 2023.

Publikationsverlauf

Eingereicht: 12. Juli 2024

Angenommen: 03. September 2024

Artikel online veröffentlicht:
30. September 2024

• References

• 1 Møller MW, Andersen MS, Glintborg D. et al. Endoscopic vs. microscopic transsphenoidal pituitary surgery: a single centre study. Sci Rep 2020; 10 (01) 21942
• 2 Gao Y, Zhong C, Wang Y. et al. Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis. World J Surg Oncol 2014; 12: 94
• 3 Younus I, Gerges MM, Dobri GA, Ramakrishna R, Schwartz TH. Readmission after endoscopic transsphenoidal pituitary surgery: analysis of 584 consecutive cases. J Neurosurg 2019; 133 (04) 1242-1247
• 4 Shimanskaya VE, Wagenmakers MAEM, Bartels RHMA. et al. Toward shorter hospitalization after endoscopic transsphenoidal pituitary surgery: day-by-day analysis of early postoperative complications and interventions. World Neurosurg 2018; 111: e871-e879
• 5 Vimawala S, Chitguppi C, Reilly E. et al. Predicting prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenoma. Int Forum Allergy Rhinol 2020; 10 (06) 785-790
• 6 Lee CC, Wang YC, Liu YT. et al. Incidence and factors associated with postoperative delayed hyponatremia after transsphenoidal pituitary surgery: a meta-analysis and systematic review. Int J Endocrinol 2021; 2021: 6659152
• 7 Bohl MA, Ahmad S, Jahnke H. et al. Delayed hyponatremia is the most common cause of 30-day unplanned readmission after transsphenoidal surgery for pituitary tumors. Neurosurgery 2016; 78 (01) 84-90
• 8 Hong YG, Kim SH, Kim EH. Delayed hyponatremia after transsphenoidal surgery for pituitary adenomas: a single institutional experience. Brain Tumor Res Treat 2021; 9 (01) 16-20
• 9 Zada G, Woodmansee WW, Iuliano S, Laws ER. Perioperative management of patients undergoing transsphenoidal pituitary surgery. Asian J Neurosurg 2010; 5 (01) 1-6
• 10 Yu S, Taghvaei M, Collopy S. et al. Evaluation of early postoperative day 1 discharge after endoscopic endonasal pituitary adenoma resection. J Neurosurg 2021; 136 (05) 1337-1346
• 11 Thomas JG, Gadgil N, Samson SL, Takashima M, Yoshor D. Prospective trial of a short hospital stay protocol after endoscopic endonasal pituitary adenoma surgery. World Neurosurg 2014; 81 (3-4): 576-583
• 12 Liu Y, Zheng T, Lv W. et al. Ambulatory surgery protocol for endoscopic endonasal resection of pituitary adenomas: a prospective single-arm trial with initial implementation experience. Sci Rep 2020; 10 (01) 9755
• 13 Sarkiss CA, Lee J, Papin JA. et al. Pilot study on early postoperative discharge in pituitary adenoma patients: effect of socioeconomic factors and benefit of specialized pituitary centers. J Neurol Surg B Skull Base 2015; 76 (04) 323-330
• 14 Pan X, Ma Y, Fang M, Jiang J, Shen J, Zhan R. Improvement in the quality of early postoperative course after endoscopic transsphenoidal pituitary surgery: description of surgical technique and outcome. Front Neurol 2020; 11: 527323
• 15 Miranda SP, Blue R, Parasher AK. et al. Implementation of a streamlined care pathway to reduce cost and length of stay for patients undergoing endoscopic transsphenoidal pituitary surgery. World Neurosurg 2023; 172: e357-e363
• 16 Hughes MA, Culpin E, Darley R. et al. Enhanced recovery and accelerated discharge after endoscopic transsphenoidal pituitary surgery: safety, patient feedback, and cost implications. Acta Neurochir (Wien) 2020; 162 (06) 1281-1286
• 17 Rizvi ZH, Ferrandino R, Luu Q, Suh JD, Wang MB. Nationwide analysis of unplanned 30-day readmissions after transsphenoidal pituitary surgery. Int Forum Allergy Rhinol 2019; 9 (03) 322-329